ClinicaliQ Trial Snapshot
- Sustained Effort Network for Treatment of Status Epilepticus/European Academy of Neurology Registry on Refractory Status Epilepticus (SENSE-II/AROUSE) — Recruiting • Neurology • NCT05839418.
- SENSE-II/AROUSE is a prospective, multicenter registry for patients treated for SE. The primary objective is to document patients and SE characteristics, treatment modalities, EEG features, and outcome of consecutive adults admitted fir SE treatment in each of the participating centers and to….
- Sponsor: Erasme University Hospital.
Verify eligibility, endpoints and current status on the original source registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
SENSE-II/AROUSE is a prospective, multicenter registry for patients treated for SE. The primary objective is to document patients and SE characteristics, treatment modalities, EEG features, and outcome of consecutive adults admitted fir SE treatment in each of the participating centers and to identify predictors of outcome and refractoriness.
Eligibility Snapshot
- : * Patients aged 18 years or above * Patients admitted for management of Status Epilepticus as their primary diagnosis * Patients admitted for another primary diagnosis but identified with Status Epilepticus during their acute hospital stay
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.